Roslin Cells is a Scottish Biotechnology company, founded in 2006 by the Roslin Institute with the support of the University of Edinburgh, the Scottish National Blood Transfusion Service and Scottish Enterprise. The company operates on a not-for-profit basis whereby any surplus revenues generated will be reinvested into stem cell research.

The Company is committed to providing high quality clinical grade pluripotent stem cells for use in therapy, screening of new drug candidates and research. The Company has developed the facilities, expertise and methodologies for the translation of cell therapies from the early fundamental research stage into GMP compliant process suitable for manufacture of product for human application.

Our People

Roslin Cells invests heavily in its primary asset - its people. Roslin Cells only recruits individuals with the skills and attributes required to meet our high scientific and quality expectations. Roslin Cells is committed to the continuous improvement of its staff who have the diversity of experience required to develop new cell therapies.